Papers: 10.1371/journal.pone.0240149

https://doi.org/10.1371/journal.pone.0240149

In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and respiratory distress caused by cytokine storm

Cited by: 52
Author(s): Laura Artigas, Mireia Coma, Pedro Matos-Filipe, Joaquim Aguirre‐Plans, Judith Farrés, Raquel Valls, Narcís Fernández-Fuentes, Juan de la Haba-Rodríguez, Àlex Olvera, José Luis Barberá, Rafael Morales, Baldo Oliva, José Manuel Mas
Published: almost 6 years ago

Software Mentions 2